Sleep Disorders Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are between 18 and 24 years old
- People who drink alcohol at high-risk levels in the past month — for women, this means 4 or more drinks in a day or 8 or more drinks per week; for men, 5 or more drinks in a day or 15 or more drinks per week
- People whose sleep on weekdays is either short and late (7.5 hours or less of sleep, going to bed at midnight or later) or long and early (more than 7.5 hours of sleep, going to bed before midnight)
- People who have experienced at least a moderate level of stressful or difficult life events (scoring 2 or more on a standard 20-item life stress checklist)
- People who are not currently attending high school
- People who are fluent in English
Who may not be able to join:
- People with a severe alcohol or substance use disorder, as assessed using standard diagnostic guidelines
- People who show alcohol in their system (a blood alcohol level of 0.02 or higher on a breathalyzer test) on the days of certain lab visits — though a reschedule may be offered
- People who currently have a doctor-diagnosed sleep disorder called narcolepsy or idiopathic hypersomnia
- People who have ever been diagnosed with bipolar disorder or a schizophrenia-related condition
- People with certain serious medical conditions, such as a significant neurological disorder, serious heart problems, or a history of head injury that caused unconsciousness for more than 5 minutes
- People with certain conditions or implants that make MRI scans unsafe (for example, having ferrous metal in the body)
- People who report having an eye disease, epilepsy, or who take certain medications that are not safe when exposed to bright light — such as some psychiatric, antimalarial, heart rhythm, or skin treatment medications (confirm with trial site)
- People who use melatonin and are not willing to stop taking it for the full duration of the study
Scheduling may be adjusted (appointments delayed) for people in these situations:
- Those assessed as being at urgent or serious risk of suicide at the time of a visit
- Those who have travelled across two or more time zones within the month before an overnight study visit
- Those who have started or stopped a prescribed medication within 2 months of the overnight study visits
- Those whose medication dose has recently changed within a timeframe based on how long that medication takes to stabilise in the body (confirm specific timeframe with trial site)
- Those who expect to change their medications or doses during the study period
- Those who have current symptoms of an airborne illness such as COVID-19 before a lab visit
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Melynda D Casement, PhD, University of Oregon
Phone: 541-346-4107
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Alcohol use; Reward-related brain function; Stress-related brain function
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.